CARMOT THERAPEUTICS, INC.

Address

409 ILLINOIS ST
SAN FRANCISCO, CA, -

Information

DUNS: 828863022
# of Employees: 0

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Drug candidates that disrupt the NEMO/IKK signaling complex for the treatment of

    Amount: $1,911,764.00

    DESCRIPTION: Drug candidates that disrupt the NEMO/IKK signaling complex for the treatment of cancer Project Summary/Abstract Protein-protein interactions represent the largest untapped opportunity f ...

    SBIRPhase II2013Department of Health and Human Services
  2. Discovery of biased small molecule agonists of the GLP-1 receptor for treatment o

    Amount: $541,527.00

    DESCRIPTION (provided by applicant): Type 2 diabetes mellitus is one of the most challenging health problems of the 21st century. Global health care expenditures to treat diabetes and its complication ...

    SBIRPhase I2012Department of Health and Human Services
  3. A novel approach to discover selective small molecule inhibitors of FABP4 and FAB

    Amount: $299,807.00

    DESCRIPTION (provided by applicant): A novel approach to discover selective small molecule inhibitors of FABP4 and FABP5 for the treatment of metabolic diseases The Western diet and lifestyle has brou ...

    SBIRPhase I2011Department of Health and Human Services
  4. Discovery of small molecule drug candidates that disrupt the NEMO/IKK signaling c

    Amount: $299,307.00

    DESCRIPTION (provided by applicant): Protein-protein interactions represent the largest untapped opportunity for therapeutic development. The number of protein-protein interactions in human cells has ...

    SBIRPhase I2010Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government